4:06 PM ET
8-K
Business Update
Citius Oncology Business Update
Citius Oncology reported preliminary fiscal fourth quarter 2026 operational metrics for its drug LYMPHIR, showing a 120% increase in unit sales to U.S. wholesalers compared to the prior quarter. The company reached 792 units sold to wholesalers and expanded its institutional reach to 54 prescribing centers as of late October.
- Term
- Q4 2026